tiprankstipranks
Trending News
More News >
Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market

Castle Biosciences (CSTL) Income Statement

Compare
459 Followers

Castle Biosciences Income Statement

Last quarter (Q4 2025), Castle Biosciences's total revenue was $87.01M, an increase of 0.81% from the same quarter last year. In Q4, Castle Biosciences's net income was $-2.33M. See Castle Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 344.23M$ 332.07M$ 219.79M$ 137.04M$ 94.08M
Gross Profit
$ 236.35M$ 271.86M$ 174.81M$ 105.03M$ 78.26M
Operating Expenses
$ 279.16M$ 263.19M$ 242.78M$ 177.88M$ 118.34M
Depreciation and Amortization
$ 40.77M$ 16.00M$ 12.33M$ 10.54M$ 3.41M
EBITDA
$ 11.34M$ 38.14M$ -45.02M$ -58.34M$ -36.60M
Operating Income
$ -42.81M$ 8.67M$ -67.98M$ -72.86M$ -40.08M
Other Income/Expenses
$ 13.30M$ 12.89M$ 10.61M$ 3.95M$ 67.00K
Pretax Income
$ -29.51M$ 21.56M$ -57.37M$ -68.90M$ -40.01M
Net Income
$ -24.16M$ 18.25M$ -57.47M$ -67.14M$ -31.29M
Per Share Metrics
Basic EPS
$ -0.83$ 0.66$ -2.14$ -2.58$ -1.24
Diluted EPS
$ -0.83$ 0.62$ -2.14$ -2.58$ -1.24
Weighted Average Shares Outstanding
28.99M 27.78M 26.80M 26.05M 25.14M
Weighted Average Shares Outstanding (Diluted)
28.99M 29.25M 26.80M 26.05M 25.14M
Currency in USD

Castle Biosciences Earnings and Revenue History